Title Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. Journal, issue, pages J. Med. Chem. , Vol. 64, Page 2228-2241, Year 2021Publish date Jan 8, 2020 (structure data deposition date) AuthorsDavis, R.R. / Li, B. / Yun, S.Y. / Chan, A. / Nareddy, P. / Gunawan, S. / Ayaz, M. / Lawrence, H.R. / Reuther, G.W. / Lawrence, N.J. / Schonbrunn, E. External links J. Med. Chem. / PubMed:33570945Methods X-ray diffraction Resolution 1.9 - 2.5 Å Structure data PDB-6vgl : Structure viewer JAK2 JH1 in complex with ruxolitinib Method : X-RAY DIFFRACTION / Resolution : 1.9 Å
PDB-6vn8 : Structure viewer JAK2 JH1 in complex with baricitinib Method : X-RAY DIFFRACTION / Resolution : 1.9 Å
PDB-6vnb : Structure viewer JAK2 JH1 in complex with BL2-084 Method : X-RAY DIFFRACTION / Resolution : 2.19 Å
PDB-6vnc : Structure viewer JAK2 JH1 in complex with BL2-096 Method : X-RAY DIFFRACTION / Resolution : 2.3 Å
PDB-6vne : Structure viewer JAK2 JH1 in complex with Fedratinib Method : X-RAY DIFFRACTION / Resolution : 2.32 Å
PDB-6vnf : Structure viewer JAK2 JH1 in complex with MA9-086 Method : X-RAY DIFFRACTION / Resolution : 2.06 Å
PDB-6vng : Structure viewer JAK2 JH1 in complex with PN2-118 Method : X-RAY DIFFRACTION / Resolution : 2.5 Å
PDB-6vnh : Structure viewer JAK2 JH1 in complex with PN2-123 Method : X-RAY DIFFRACTION / Resolution : 2.4 Å
PDB-6vni : Structure viewer JAK2 JH1 in complex with PN3-115 Method : X-RAY DIFFRACTION / Resolution : 2.1 Å
PDB-6vnj : Structure viewer JAK2 JH1 in complex with PN4-014 Method : X-RAY DIFFRACTION / Resolution : 1.9 Å
PDB-6vnk : Structure viewer JAK2 JH1 in complex with PN4-073 Method : X-RAY DIFFRACTION / Resolution : 2 Å
PDB-6vnl : Structure viewer JAK2 JH1 in complex with SG3-179 Method : X-RAY DIFFRACTION / Resolution : 2.4 Å
PDB-6vnm : Structure viewer JAK2 JH1 in complex with SY5-103 Method : X-RAY DIFFRACTION / Resolution : 2.2 Å
PDB-6vs3 : Structure viewer JAK2 JH1 in complex with BL2-057 Method : X-RAY DIFFRACTION / Resolution : 2 Å
PDB-6vsn : Structure viewer JAK2 JH1 in complex with BL2-110 Method : X-RAY DIFFRACTION / Resolution : 2.5 Å
Chemicals ChemComp-RXT : Structure viewer (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile / medication, inhibitor*YM
ChemComp-3JW : Structure viewer Baricitinib / medication, inhibitor*YM
ChemComp-R6P : Structure viewer (3S)-3-cyclopentyl-3-[4-(2-{[4-(piperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
ChemComp-R6V : Structure viewer (3R)-3-cyclopentyl-3-[4-(2-{[4-(piperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
ChemComp-2TA : Structure viewer N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide / medication, anticancer*YM
ChemComp-R6S : Structure viewer N~4~-[1-(tert-butylsulfonyl)-2,3-dihydro-1H-indol-6-yl]-N~2~-[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]-5-methylpyrimidine-2,4-diamine
ChemComp-R6M : Structure viewer N-{2-fluoro-5-[(2-{[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]phenyl}-2-methylpropane-2-sulfonamide
ChemComp-XZS : Structure viewer N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide
ChemComp-R61 : Structure viewer 2-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-1lambda~6~,2-thiazolidine-1,1-dione
ChemComp-R5S : Structure viewer 3-[4-(2-{[4-(piperidin-4-yl)phenyl]amino}-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
ChemComp-5W2 : Structure viewer 4-[[4-[[3-(~{tert}-butylsulfonylamino)-4-chloranyl-phenyl]amino]-5-methyl-pyrimidin-2-yl]amino]-2-fluoranyl-~{N}-(1-methylpiperidin-4-yl)benzamide
ChemComp-R5Y : Structure viewer 4-[1-(but-3-en-1-yl)-1H-pyrazol-4-yl]-N-[4-(piperidin-4-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine
ChemComp-RG4 : Structure viewer (3S)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
Source homo sapiens (human) Keywords TRANSFERASE/TRANSFERASE INHIBITOR / Janus associated kinase / JAK2 / kinase domain / JH1 / kinase / TRANSFERASE-TRANSFERASE INHIBITOR complex / TRANSFERASE